Treosulfan-Based Conditioning and Hematopoietic Cell Transplantation for Nonmalignant Diseases: A Prospective
Lauri M. Burroughs(Fred Hutch Cancer Center), Ann E. Woolfrey(University of Washington), Suzanne Skoda‐Smith(University of Washington), K. Scott Baker(Malaria Consortium), Colleen Delaney(Seattle Children's Hospital), Jennifer Domm(Vanderbilt University), David J. Rawlings(Center for Infectious Disease Research), Eneida R. Nemecek(Oregon Health & Science University), Akiko Shimamura(Harvard University), Roger Giller(Center for Cancer and Blood Disorders), Janet A. Englund(Seattle Children's Hospital), Barry E. Storer(City Of Hope National Medical Center), Troy R. Torgerson(Allen Institute for Immunology), Rainer Storb(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Monica S. Thakar(Fred Hutch Cancer Center), Julie‐An Talano(Dana-Farber Cancer Institute), H. Joachim Deeg(Fred Hutch Cancer Center)
Unknown
January 1, 2014
Cited by 0
Related Papers
Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia
|New England Journal of Medicine|2018|5.7k
Chronic graft-versus-host syndrome in man
|The American Journal of Medicine|1980|2.4k
HLA-Haploidentical Bone Marrow Transplantation for Hematologic Malignancies Using Nonmyeloablative Conditioning and High-Dose, Posttransplantation Cyclophosphamide
|Biology of Blood and Marrow Transplantation|2008|1.9k
Methotrexate and Cyclosporine Compared with Cyclosporine Alone for Prophylaxis of Acute Graft versus Host Disease after Marrow Transplantation for Leukemia
|New England Journal of Medicine|1986|1.5k